Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return

Tan, Litjen J.; Ahmed, Syed; Rothholz, Mitchel C.; Kassianos, George; Nguyen-Van-Tam, Jonathan S.

Abstract

During the COVID-19 pandemic, immunization programs for other respiratory infections, notably influenza continued worldwide but attracted less public or political attention than COVID-19 vaccinations. Due to non-pharmaceutical intervention measures the global influenza burden decreased substantially; but with lifting of restrictions a rebound in other respiratory virus pathogens is both plausible and likely. This article discusses lessons identified from the UK and USA, and provides recommendations for future influenza vaccination programs in light of emerging data from the southern hemisphere and the need for harmonization with COVID-19 vaccination, focusing on operational delivery and messaging to practitioners and the public.

Citation

Tan, L. J., Ahmed, S., Rothholz, M. C., Kassianos, G., & Nguyen-Van-Tam, J. S. (2022). Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return. Human Vaccines and Immunotherapeutics, 18(6), Article 2125754. https://doi.org/10.1080/21645515.2022.2125754

• Journal Article Type: Article
• Acceptance Date: Sep 13, 2022
• Online Publication Date: Sep 26, 2022
• Publication Date: Sep 26, 2022
• Deposit Date: Oct 27, 2022
• Publicly Available Date: Oct 27, 2022
• Journal: Human Vaccines and Immunotherapeutics
• Print ISSN: 2164-5515
• Electronic ISSN: 2164-554X
• Publisher: Taylor and Francis
• Peer Reviewed: Peer Reviewed
• Volume: 18
• Issue: 6
• Article Number: 2125754
• DOI: https://doi.org/10.1080/21645515.2022.2125754
• Keywords: Pharmacology; Immunology; Immunology and Allergy
• Public URL: https://nottingham-repository.worktribe.com/output/12317223
• Publisher URL: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2125754